Teachers Advisors’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Teachers Advisors’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$785K	Buy	35,038 +6,917	+25%	+$149K	﹤0.01%	2386
2018 Q4	$512K	Hold	28,121	–	–	﹤0.01%	2499
2018 Q3	$509K	Sell	28,121 -199	-0.7%	-$2.36K	﹤0.01%	2631
2018 Q2	$282K	Buy	28,320 +7,576	+37%	+$52.3K	﹤0.01%	2889
2018 Q1	$110K	Hold	20,744	–	–	﹤0.01%	2938
2017 Q4	$176K	Hold	20,744	–	–	﹤0.01%	2954
2017 Q3	$303K	Hold	20,744	–	–	﹤0.01%	2827
2017 Q2	$389K	Buy	20,744 +11,834	+133%	+$267K	﹤0.01%	2723
2017 Q1	$190K	Hold	8,910	–	–	﹤0.01%	2886
2016 Q4	$135K	Buy	+8,910	New	+$121K	﹤0.01%	2973

Other funds holding RARX

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MMPI

Morgenthaler Management Partners IX Portola Valley, California $22.6M AUM

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Teachers Advisors's RARX Position: Q1 2019 in Review

Teachers Advisors increased its Ra Pharmaceuticals, Inc. Common Stock (RARX) stake by 25% in Q1 2019, buying an estimated $149K and bringing the position to 35,038 shares worth $785K. The position accounts for ﹤0.01% of the portfolio, ranked #2386.

Teachers Advisors first reported a position in RARX in Q4 2016 and has held it in 10 quarters since. 124 funds tracked by Wall St. Rank hold RARX as of Q1 2019.

Teachers Advisors held 35,038 shares of Ra Pharmaceuticals, Inc. Common Stock worth $785K as of Q1 2019.
Teachers Advisors bought 6,917 Ra Pharmaceuticals, Inc. Common Stock shares in Q1 2019, an estimated $149K.
Ra Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2386 holding.
Teachers Advisors first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2016 and has held it in 10 quarters since.
124 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.